U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07102628) titled 'Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes' on July 31.
Brief Summary: The purpose of this trial is to learn about the effects of inclisiran in people with serious heart conditions (acute coronary syndromes), when this treatment is started early after hospital admission. To do this, researchers will test the effects of inclisiran compared to placebo, when given with standard treatment.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Acute Coronary Syndrome
Intervention:
DRUG: Placebo
The participants will receive placebo s...